Table 5.
Burden of selected concomitant co-morbidities 2010
| Disease | Men | Women | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| (Year 2010) | Standardized prevalence rates (95 % CI) | SPR (95%CI) | Standardized prevalence rates (95 % CI) | SPR (95 % KI) | Standardized prevalence rates (95 % CI) | SPR (95 % CI) | |||
| Without T2DM | With T2DM | Without T2DM | With T2DM | Without T2DM | With T2DM | ||||
| Adiposity | 5.99 (5.97-6.01) | 27.11 (26.95-27.26) | 4.53 (1.87-10.96) | 9.83 (9.81-9.86) | 34.49 (34.32-34.66) | 3.51 (1.73-7.12) | 8.08 (8.07-8.10) | 31.13 (31.02-31.25) | 3.85 (1.78-8.35) |
| Hypertension | 17.84 (17.80-17.87) | 74.68 (74.43-74.93) | 4.19 (2.50-7.02) | 20.84 (20.80-20.88) | 79.12 (78.87-79.38) | 3.8 (2.34-6.15) | 19.37 (19.34-19.40) | 77.01 (76.83-77.19) | 3.98 (2.42-6.54) |
| Coronary heart disease | 4.71 (4.69-4.73) | 27.77 (27.61-27.92) | 5.89 (2.22-15.65) | 3.32 (3.31-3.34) | 18.95 (18.83-19.08) | 5.70 (1.78-18.29) | 3.32 (3.31-3.34) | 22.99 (22.89-23.08) | 5.84 (2.01-17.02) |
| Stroke | 0.70 (0.69-0.71) | 4.73 (4.67-4.80) | 6.77 (0.55-83.35) | 0.60 (0.59-0.61) | 3.66 (3.61-3.72) | 6.10 (0.4-93.4) | 0.64 (0.64-0.65) | 4.15 (4.11-4.19) | 6.47 (0.47-89.7) |
| Renal insufficiency | 1.43 (1.42-1.44) | 8.65 (8.56-8.73) | 6.06 (1.03-35.66) | 1.08 (1.07-1.09) | 6.69 (6.62-6.76) | 6.2 (0.81-47.33) | 1.23 (1.22-1.24) | 7.57 (7.52-7.63) | 6.17 (0.92-41.5) |
| Retinopathy | 2.61 (2.60-2.62) | 23.71 (23.57-23.85) | 9.08 (2.53-32.61) | 3.82 (3.80-3.84) | 25.86 (25.71-26.00) | 6.77 (2.31-19.82) | 3.24 (3.23-3.25) | 24.83 (24.73-24.93) | 7.66 (2.41-24.37) |
The standardized prevalence ratios are shown for adiposity and several vascular determined concomitant diseases comparing insured persons with and without type 2 diabetes mellitus (T2DM). The prevalence rates were standardized for age and sex on the residual population of South Western Germany of the respective year with 95 % confidence intervals (CI) (SPR = standardized prevalence ratio)